|
| 36809715 | IL-4, IL-13 and IFN-γ -induced genes in highly purified human neutrophils. | Cytokine | 2023 |
| 37595410 | Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue. | J Autoimmun | 2023 |
| 37747317 | IL-15 Priming Alters IFN-γ Regulation in Murine NK Cells. | J Immunol | 2023 |
| 37153622 | IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium. | Front Immunol | 2023 |
| 37207205 | The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion. | Front Immunol | 2023 |
| 36809715 | IL-4, IL-13 and IFN-γ -induced genes in highly purified human neutrophils. | Cytokine | 2023 |
| 37185821 | IFN-γ and androgens disrupt mitochondrial function in murine myocytes. | J Pathol | 2023 |
| 37595410 | Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue. | J Autoimmun | 2023 |
| 37747317 | IL-15 Priming Alters IFN-γ Regulation in Murine NK Cells. | J Immunol | 2023 |
| 37185821 | IFN-γ and androgens disrupt mitochondrial function in murine myocytes. | J Pathol | 2023 |
| 37153622 | IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium. | Front Immunol | 2023 |
| 37207205 | The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion. | Front Immunol | 2023 |
| 34783257 | Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic. | Immunotherapy | 2022 |
| 36042351 | Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression. | Cell Mol Immunol | 2022 |
| 36029718 | Dual B-cell targeting therapy ameliorates autoimmune cholangitis. | J Autoimmun | 2022 |
| 36330506 | Exploring the immunomodulatory role of virtual memory CD8<sup>+</sup> T cells: Role of IFN gamma in tumor growth control. | Front Immunol | 2022 |
| 36516376 | A Personal Perspective on My Scientific Career. | J Interferon Cytokine Res | 2022 |
| 34783257 | Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic. | Immunotherapy | 2022 |
| 36516376 | A Personal Perspective on My Scientific Career. | J Interferon Cytokine Res | 2022 |
| 36042351 | Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression. | Cell Mol Immunol | 2022 |
| 36330506 | Exploring the immunomodulatory role of virtual memory CD8<sup>+</sup> T cells: Role of IFN gamma in tumor growth control. | Front Immunol | 2022 |
| 36029718 | Dual B-cell targeting therapy ameliorates autoimmune cholangitis. | J Autoimmun | 2022 |
| 33972783 | Promise and complexity of lupus mouse models. | Nat Immunol | 2021 |
| 33972783 | Promise and complexity of lupus mouse models. | Nat Immunol | 2021 |
| 34114369 | Cytokines: From Clinical Significance to Quantification. | Adv Sci (Weinh) | 2021 |
| 33723418 | Lessons learned: new insights on the role of cytokines in COVID-19. | Nat Immunol | 2021 |
| 34521758 | Using PET imaging to track STING-induced interferon signaling. | Proc Natl Acad Sci U S A | 2021 |
| 34642183 | Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages. | Cancer Res | 2021 |
| 33723418 | Lessons learned: new insights on the role of cytokines in COVID-19. | Nat Immunol | 2021 |
| 34642183 | Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages. | Cancer Res | 2021 |
| 34521758 | Using PET imaging to track STING-induced interferon signaling. | Proc Natl Acad Sci U S A | 2021 |
| 34114369 | Cytokines: From Clinical Significance to Quantification. | Adv Sci (Weinh) | 2021 |
| 31622780 | Adaptive in vivo device for theranostics of inflammation: Real-time monitoring of interferon-γ and aspirin. | Acta Biomater | 2020 |
| 31622780 | Adaptive in vivo device for theranostics of inflammation: Real-time monitoring of interferon-γ and aspirin. | Acta Biomater | 2020 |
| 32220507 | Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases. | J Autoimmun | 2020 |
| 33379198 | IFNγ is a Key Link between Obesity and Th1-Mediated AutoImmune Diseases. | Int J Mol Sci | 2020 |
| 32925169 | Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients. | J Clin Invest | 2020 |
| 33028646 | Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumors. | Cold Spring Harb Mol Case Stud | 2020 |
| 32855555 | The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge. | Nat Immunol | 2020 |
| 33379198 | IFNγ is a Key Link between Obesity and Th1-Mediated AutoImmune Diseases. | Int J Mol Sci | 2020 |
| 33028646 | Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumors. | Cold Spring Harb Mol Case Stud | 2020 |
| 32855555 | The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge. | Nat Immunol | 2020 |
| 32925169 | Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients. | J Clin Invest | 2020 |
| 32220507 | Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases. | J Autoimmun | 2020 |
| 30608984 | Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of "innate" characteristics during CD8+ T cell development. | PLoS Pathog | 2019 |
| 30608984 | Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of "innate" characteristics during CD8+ T cell development. | PLoS Pathog | 2019 |
| 31063862 | Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study. | J Thorac Oncol | 2019 |
| 30998425 | Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential. | J Interferon Cytokine Res | 2019 |
| 30988117 | Report on the 2018 Cancer, Autoimmunity, and Immunology Conference. | J Immunol | 2019 |
| 30988117 | Report on the 2018 Cancer, Autoimmunity, and Immunology Conference. | J Immunol | 2019 |